Laboratory of Pathology, Hematopathology Section.
Molecular Diagnostics, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
Am J Surg Pathol. 2024 Apr 1;48(4):426-436. doi: 10.1097/PAS.0000000000002160. Epub 2023 Nov 21.
Tissue eosinophilia is seldom reported in B-cell lymphoma. It poses diagnostic challenges and frequently leads to the consideration of other diagnoses, particularly T-cell lymphomas. The scarce literature underscores the need for in-depth studies to enhance awareness and understanding of this phenomenon. We investigated 54 cases of B-cell lymphoma with notable tissue eosinophils, analyzing clinical information, hematoxylin and eosin staining, immunohistochemistry, and PCR-based clonality analysis. Nodal marginal zone lymphoma (NMZL) emerged as the most prevalent type (n=26), followed by B-cell lymphoma, not otherwise specified (n=13), diffuse large B-cell lymphoma (n=10), follicular lymphoma (n=2), chronic lymphocytic leukemia/small lymphocytic lymphoma (n=1), extranodal marginal zone lymphoma (n=1), and primary cutaneous marginal zone lymphoma (n=1). Shared features across different lymphoma types, best exemplified by NMZL, included plasmacytic differentiation (57.7%), increased vascularity (84.6%) with a tendency for perivascular distribution of neoplastic cells, and a tumor microenvironment abundant in T cells and histiocytes; some cases showed increased PD-1-positive cells. These features often raise consideration of angioimmunoblastic T-cell lymphoma. Along with clonality analysis, features supporting the diagnosis of B-cell lymphoma included cytological atypia in B cells rather than T cells, and the lack of follicular dendritic cell meshwork expansion. In addition, diffuse large B-cell lymphoma frequently exhibited interfollicular distribution and monocytoid appearance, indicating the possibility of transformed NMZL. Collectively, tissue eosinophilia can occur in diverse B-cell lymphomas but is most prevalent in tumors with a postgerminal stage of differentiation.
组织嗜酸性粒细胞增多在 B 细胞淋巴瘤中很少见报道。它给诊断带来了挑战,常常导致其他诊断的考虑,特别是 T 细胞淋巴瘤。这方面的文献很少,强调需要深入研究,以提高对这一现象的认识和理解。我们研究了 54 例有明显组织嗜酸性粒细胞的 B 细胞淋巴瘤,分析了临床资料、苏木精和伊红染色、免疫组织化学和基于聚合酶链反应的克隆性分析。结外边缘区淋巴瘤(NMZL)是最常见的类型(n=26),其次是 B 细胞淋巴瘤,其他未特指(n=13)、弥漫性大 B 细胞淋巴瘤(n=10)、滤泡性淋巴瘤(n=2)、慢性淋巴细胞白血病/小淋巴细胞淋巴瘤(n=1)、结外边缘区淋巴瘤(n=1)和原发性皮肤边缘区淋巴瘤(n=1)。不同淋巴瘤类型之间存在共同特征,以 NMZL 最为典型,包括浆细胞分化(57.7%)、血管增多(84.6%),肿瘤细胞有向血管周围分布的趋势,以及富含 T 细胞和组织细胞的肿瘤微环境;一些病例显示 PD-1 阳性细胞增多。这些特征常常提示考虑血管免疫母细胞性 T 细胞淋巴瘤。结合克隆性分析,支持 B 细胞淋巴瘤诊断的特征包括 B 细胞而不是 T 细胞的细胞学异型性,以及缺乏滤泡树突状细胞网状扩张。此外,弥漫性大 B 细胞淋巴瘤常表现为滤泡间分布和单核细胞样外观,提示可能是转化型 NMZL。总之,组织嗜酸性粒细胞增多可发生在多种 B 细胞淋巴瘤中,但在具有生发后分化阶段的肿瘤中最为常见。